1-(4-fluorophenyl)pyrrole-3-carboxylic acid | 288251-68-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 英文名称: 1-(4-fluorophenyl)pyrrole-3-carboxylic acid
• 英文别名: 1-(4-fluorophenyl)-1H-pyrrole-4-carboxylic acid
• CAS: 288251-68-3
• 化学式: C₁₁H₈FNO₂
• 分子量: 205.188
• InChiKey: MMARDHMNEVDVHF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-(4-fluorophenyl)pyrrole-3-carboxylic acid 在 正丁基锂 、 二苯基膦叠氮化物 、 三乙胺 作用下， 以 四氢呋喃 、 苯 为溶剂， 反应 7.5h， 生成 (R)-3-[1-(4-Fluoro-phenyl)-1H-pyrrol-3-yl]-5-hydroxymethyl-oxazolidin-2-one
  参考文献：
  名称：

  Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480

  摘要：

  Pursuing our search program for new antitubercular drugs we decided to explore the potentiality of oxazolidinone moiety by synthesizing novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480. The new derivatives were tested against atypical mycobacteria as well as against drug resistant Mycobacterium tuberculosis and some of them exhibited a fairly good activity against Mycobacterium avium complex (MAC). (C) 2004 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2004.01.010
• 作为产物：
  描述：

  1-(4-氟苯基)吡咯 在 potassium permanganate 、 三氟甲磺酸 、 三氯氧磷 作用下， 以 水 、 1,2-二氯乙烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 生成 1-(4-fluorophenyl)pyrrole-3-carboxylic acid
  参考文献：
  名称：

  롤 화장지 인출장치

  摘要：

  该设想旨在提供一种方便使用者将卷纸卫生纸卷取到所需长度并剪断后，当侧面脱落时能够轻松取出而无褶皱或撕裂的卷纸卫生纸取出装置，以确保便利性。该设想的上述目的通过提供一种卷纸卫生纸取出装置实现，该装置包括在安装在墙体上的盒体内部上侧配备的卷芯，通过将装有卷纸卫生纸的卷芯插入盒体底部以提取，并通过“ㄷ”字形旋转翼片将其卷成适当长度，然后从侧面取出使用的卷纸卫生纸取出装置，其中，在卷纸卫生纸取出装置中，通过在“ㄷ”字形旋转翼片的内侧配备另一个“ㄷ”字形支撑翼片，使其相互交叉状态，然后在每个旋转翼片和支撑翼片的外周上将卷纸卫生纸卷取到适当长度后剪断，并通过支撑翼片的反向旋转使卷纸卫生纸的卷曲状态变松，从而使其能够从侧面取出并使用。

  公开号：

  KR20150002661U

文献信息

• AMIDE DERIVATIVE AND USE THEREOF
  申请人：Ushio Hiroyuki

  公开号：US20130211075A1

  公开（公告）日：2013-08-15

  The present invention relates to a novel amide derivative. More specifically, the present invention provides a medicinal agent useful as a prophylactic or therapeutic agent for diseases, which relies on the production of cytokines from T cells, and which comprises an amide derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or the pharmacologically acceptable salt as an active ingredient. Provided is an amide derivative represented by general formula (I) [wherein each symbol is as defined in the description] or a pharmacologically acceptable salt thereof, or a solvate of the derivative or the pharmacologically acceptable salt.

  本发明涉及一种新型酰胺衍生物。更具体地说，本发明提供了一种药用剂，可用作依赖于T细胞产生细胞因子的疾病的预防或治疗剂，该药用剂包括酰胺衍生物或其药理学上可接受的盐或该衍生物或药理学上可接受的盐的溶剂的溶剂作为活性成分。提供的是由通式(I)所表示的酰胺衍生物[其中每个符号如描述中所定义]或其药理学上可接受的盐，或该衍生物或药理学上可接受的盐的溶剂。
• Tetrahydronaphthalenylamides, a process for their production and their use as anti-inflammatory agents
  申请人：Bayer Schering Pharma Aktiengesellschaft

  公开号：EP1958934A1

  公开（公告）日：2008-08-20

  The present invention relates to the compounds of formula I, processes for their production and their use as anti-inflammatory agents.

  本发明涉及公式I的化合物，其制备过程以及作为抗炎剂的用途。
• TETRAHYDRONAPHTHALENYLAMIDES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
  申请人：BERGER Markus

  公开号：US20080200519A1

  公开（公告）日：2008-08-21

  The present invention relates to the compounds of formula I, processes for their production and their use as anti-inflammatory agents.

  本发明涉及式I的化合物，其生产过程及其作为抗炎剂的用途。
• AMIDOPYRIDINE DERIVATIVE AND USE THEREOF
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：US20150065715A1

  公开（公告）日：2015-03-05

  The present invention relates to novel amidopyridine derivatives. More specifically, the present invention provides a medicinal agent which is useful as a prophylactic or therapeutic agent for diseases based on the production of cytokines from T cells, comprising as the active ingredient an amidopyridine derivative or a pharmacologically acceptable salt thereof. Provided are an amidopyridine derivative of the following general formula (I): wherein each symbol has the same meaning as defined in the description, or a pharmacologically acceptable salt thereof.

  本发明涉及新型的酰胺吡啶衍生物。更具体地说，本发明提供了一种药物剂，其作为预防或治疗基于T细胞产生细胞因子的疾病的药物剂，包括酰胺吡啶衍生物或其药理学上可接受的盐作为活性成分。提供了以下一般式（I）的酰胺吡啶衍生物，其中每个符号具有与描述中定义的相同含义，或其药理学上可接受的盐。
• Amide derivative and use thereof
  申请人：Ushio Hiroyuki

  公开号：US09150555B2

  公开（公告）日：2015-10-06

  The present invention relates to a novel amide derivative. More specifically, the present invention provides a medicinal agent useful as a prophylactic or therapeutic agent for diseases, which relies on the production of cytokines from T cells, and which comprises an amide derivative or a pharmacologically acceptable salt thereof or a solvate of the derivative or the pharmacologically acceptable salt as an active ingredient. Provided is an amide derivative represented by general formula (I) [wherein each symbol is as defined in the description] or a pharmacologically acceptable salt thereof, or a solvate of the derivative or the pharmacologically acceptable salt.

  本发明涉及一种新型酰胺衍生物。更具体地说，本发明提供了一种药物剂，其可作为预防或治疗疾病的药物剂，依赖于T细胞产生细胞因子，并包括酰胺衍生物或其药理学上可接受的盐或衍生物或药理学上可接受的盐的溶剂作为活性成分。提供了一种由通式（I）表示的酰胺衍生物[其中每个符号如定义中所述]或其药理学上可接受的盐，或其衍生物或药理学上可接受的盐的溶剂。